CJC-1295 No DAC 5mg and Ipamorelin 5mg Blend for Research
Unlock the potential of peptide research with our premium CJC-1295 No DAC 5mg and Ipamorelin 5mg blend, a meticulously crafted peptide combination tailored for cutting-edge scientific studies. This high-purity blend, offering 10mg of lyophilized powder per vial, is designed to support researchers investigating the intricate mechanisms of growth hormone (GH) secretion, metabolic regulation, and tissue repair in non-human models. By combining CJC-1295 No DAC (Modified GRF 1-29) and Ipamorelin, two potent growth hormone secretagogues, this blend delivers synergistic effects that amplify GH release, making it a cornerstone for studies exploring muscle development, fat loss, and recovery processes.
What is CJC-1295 No DAC?
CJC-1295 No DAC, also known as Modified GRF (1-29), is a synthetic analog of growth hormone-releasing hormone (GHRH). Comprising 29 amino acids with four strategic substitutions to enhance stability, it stimulates the pituitary gland’s GHRH receptors to promote pulsatile GH secretion. Unlike CJC-1295 with DAC, which has a prolonged half-life due to its drug affinity complex, CJC-1295 No DAC has a shorter half-life of approximately 30 minutes, allowing for precise control in research settings. Studies, such as those published in the Journal of Clinical Endocrinology & Metabolism, have demonstrated that CJC-1295 can increase GH levels by 200-1000% for up to six days, making it a powerful tool for investigating GH dynamics.
What is Ipamorelin?
Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist, a pentapeptide known for its specificity in stimulating GH release without affecting other hormones like cortisol or prolactin. With a half-life of about 2 hours, Ipamorelin induces rapid, short-lived GH spikes, complementing the sustained action of CJC-1295 No DAC. Research, including a 1998 study in the European Journal of Endocrinology, highlights Ipamorelin’s role in counteracting glucocorticoid-induced bone loss and improving gastric motility, underscoring its versatility in metabolic and musculoskeletal studies.
Synergistic Power of the CJC-1295 No DAC and Ipamorelin Blend
The CJC-1295 No DAC and Ipamorelin blend leverages complementary mechanisms to maximize GH secretion in research subjects. CJC-1295 No DAC enhances the amplitude of GH pulses by acting on GHRH receptors, while Ipamorelin amplifies the frequency of these pulses through ghrelin receptor activation. This dual-action approach results in a 3-5 fold increase in GH release compared to either peptide alone, as noted in clinical research settings. The blend’s synergy creates a higher baseline for GH levels while preserving the natural pulsatile secretion pattern, offering researchers a robust platform to study:
-
Muscle Growth and Repair: Enhanced protein synthesis and nitrogen retention for lean muscle development.
-
Fat Metabolism: Accelerated lipolysis and improved insulin sensitivity for fat loss studies.
-
Recovery Processes: Faster tissue repair and reduced recovery times in non-human models.
-
Metabolic Function: Improved bowel motility, bone density, and cognitive performance.
This product is strictly for research purposes and not intended for human or animal use. Handle with care, following proper laboratory protocols. Store in a refrigerator at 2-8°C to maintain stability, and reconstitute with bacteriostatic water as per research requirements.
There are no reviews yet.